Clin2
NCT07501884Possibly a fitNot yet recruiting

Medication to reduce bleeding during urethral surgery

Urethral StrictureUrethral Diseases

Treatments studied

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether a medicine called tranexamic acid (TXA) can reduce bleeding during urethroplasty surgery. If it works, it may help you recover with fewer complications.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years old or older.
  • You are scheduled to have a urethroplasty, a surgery to widen a narrowed urethra.
  • You do not have a history of blood clots (like deep vein thrombosis, stroke, or lung clot).
  • You do not have bleeding problems or take blood thinners that cannot be stopped, have severe kidney issues, or a history of seizures.
  • You are not allergic to tranexamic acid and can give consent.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04312880Enrolling by invitation· Phase 4
Tranexamic acid during elective back surgery to reduce bleeding

This trial studies whether giving tranexamic acid (a medicine that helps reduce bleeding) during planned lower-back decompression surgery can lower blood loss or related complications. It compares patients who receive the infusion during surgery to those who meet study procedures and safety requirements.

Albany, New York
NCT07494032Not yet recruiting
Extended tranexamic acid after total knee replacement

This study tests whether taking tranexamic acid (a medication that helps blood clot) for a few days after knee replacement surgery can reduce bleeding and the need for blood transfusions. It may help patients recover with fewer complications.

New York, New York
NCT07460518Recruiting· Phase 4
Tranexamic acid for reducing bleeding during prostate surgery

This trial tests whether a medicine called tranexamic acid, given during surgery to remove part of the prostate, can reduce bleeding. If you are scheduled for this type of prostate surgery, this treatment might help make the procedure safer and improve recovery.

Rabat
NCT06657924Recruiting· Phase 2
TXA to Prevent Bleeding in Colorectal Surgery

This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.

Cleveland, Ohio
NCT07614087Not yet recruiting· Phase 4
Bleeding medicine during hip or knee replacement

This study measures how a medicine called tranexamic acid (which helps reduce bleeding) works when given through a needle in the bone versus in a vein during hip or knee replacement surgery. It may help your surgeon choose the best way to control bleeding during your operation.

Linhai, Zhejiang
NCT06710327Not yet recruiting· Phase 4
Tranexamic acid to reduce bleeding during aquablation for enlarged prostate

This study tests whether giving a medicine called tranexamic acid before Aquablation surgery helps reduce bleeding during the procedure. The goal is to see if it makes the surgery safer and reduces blood loss for men with an enlarged prostate.

Los Angeles, California

Hear when a new Urethral Stricture trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.